Newborn screening and the pediatric practitioner

Seminars in Perinatology

Volumn 29, Issue 3 SPEC. ISS., 2005, Pages 182-188

  Seashore, Margretta R ^a   Seashore, Carl J ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acylcarnitine; Collaborative care; Medical home; Newborn screening; Public health; Tandem mass spectrometry; Uniform core panel of disorders

Indexed keywords

ACYLCARNITINE; AMINO ACID; ARGININE; CARBOXYLIC ACID; CITRULLINE; FATTY ACID; ISOLEUCINE; LEUCINE; METHIONINE; PHENYLALANINE; TYROSINE; VALINE;

CARNITINE UPTAKE DISORDER; CITRULLINEMIA; CYSTIC FIBROSIS; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DNA MICROARRAY; ETHICS; FATTY ACID OXIDATION; FOLLOW UP; HEALTH CARE; HEMOGLOBINOPATHY; HOMOCYSTINURIA; HUMAN; HYPERPHENYLALANINEMIA; INBORN ERROR OF METABOLISM; ISOVALERIC ACIDEMIA; LABORATORY TEST; MEDICAL SPECIALIST; METABOLIC DISORDER; METHYLMALONIC ACIDEMIA; NEWBORN SCREENING; PEDIATRICIAN; PHENYLKETONURIA; PRIORITY JOURNAL; PROPIONIC ACIDEMIA; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; REVIEW; TRIFUNCTIONAL PROTEIN DEFICIENCY; TYROSINEMIA; WORLD HEALTH ORGANIZATION;

EID: 21344462141     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2005.05.001     Document Type: Article

References (54)

1. Newborn screening. a blueprint for the future executive summary: newborn screening task force report Pediatrics 106 2000 386 388
2. D.C. Lehotay, J. LePage, J.R. Thompson Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency a relationship between genotype and biochemical phenotype? J Inherit Metab Dis 27 2004 81 88
3. R. Guthrie The introduction of newborn screening for phenylketonuria A personal history Eur J Pediatr 155 suppl 1 1996 S4 S5
4. R. Guthrie, A. Susi A simple phenlyalanine method for detecting phenylketonuria in large populations of newborn infants Pediatrics 32 1963 338 343
5. W.B. Hanley, H. Demshar, M.A. Preston Newborn phenylketonuria (PKU) Guthrie (BIA) screening and early hospital discharge Early Hum Dev 47 1997 87 96
6. D.B. Allen, P.M. Farrell Newborn screening principles and practice Adv Pediatr 43 1996 231 270
7. K.G. Bryant, K.M. Horns, N. Longo A primer on newborn screening Adv Neonatal Care 4 2004 306 317
8. A. Clague, A. Thomas Neonatal biochemical screening for disease Clin Chim Acta 315 2002 99 110
9. American Academy of Pediatrics, Committee on Genetics Newborn screening fact sheets Pediatrics 98 1996 473 501
10. B. Inoue, M. Hata, Y. Ichiba Results of newborn screening for galactose metabolic disorders J Inherit Metab Dis 13 1990 93 101
11. E. Carreiro-Lewandowski Newborn screening an overview Clin Lab Sci 15 2002 229 238
12. L.J. Raffel, T.M. Cowan, M.G. Blitzer Transient neonatal galactosaemia identified by newborn screening J Inherit Metab Dis 16 1993 894 895
13. H.L. Levy, S. Albers Genetic screening of newborns Annu Rev Genom Hum Genet 1 2000 139 177
14. M.R. Seashore Tandem spectrometry in newborn screening Curr Opin Pediatr 10 1998 609 614
15. M.K. Fearing, H.L. Levy Expanded newborn screening using tandem mass spectrometry Adv Pediatr 50 2003 81 111
16. S.M. Dunigan, S.B. Walker, M.R. Seashore Newborn screening for urea cycle disorders Mol Genet Metab 84 2005 216
17. Newborn screening. toward a uniform screening panel and system Report for Public Comment 2005 Available at: http://www.mchb.hrsa.gov/screening. Accessed March 8
18. B.L. Therrell Jr U.S. newborn screening policy dilemmas for the twenty-first century Mol Genet Metab 74 2001 64 74
19. C.R. Roe Inherited disorders of mitochondrial fatty acid oxidation a new responsibility for the neonatologist Semin Neonatol 7 2002 37 47
20. F. Desposito, M.A. Lloyd-Puryear, T.F. Tonniges Survey of pediatrician practices in retrieving statewide authorized newborn screening results Pediatrics 108 2001 E22
21. S. Kim, M.A. Lloyd-Puryear, T.F. Tonniges Examination of the communication practices between state newborn screening programs and the medical home Pediatrics 111 2003 E120 E126
22. Serving the family from birth to the medical home. Newborn screening. a blueprint for the future-a call for a national agenda on state newborn screening programs Pediatrics 106 2000 389 422
23. D.H. Chace, T.A. Kalas, E.W. Naylor The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism Annu Rev Genom Hum Genet 3 2002 17 45
24. N. Gregersen, P. Bross, B.S. Andresen Genetic defects in fatty acid beta-oxidation and acyl-CoA dehydrogenases Molecular pathogenesis and genotype-phenotype relationships. Eur J Biochem 271 2004 470 482
25. P.M. Jones, M.J. Bennett The changing face of newborn screening diagnosis of inborn errors of metabolism by tandem mass spectrometry Clin Chim Acta 324 2002 121 128
26. S.S. Wang, P.M. Fernhoff, W.H. Hannon Medium chain acyl-CoA dehydrogenase deficiency human genome epidemiology review Genet Med 1 1999 332 339
27. B.S. Andresen, S.F. Dobrowolski, L. O'Reilly Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency Am J Hum Genet 68 2001 1408 1418
28. E.R. Baumgartner, T. Suormala Multiple carboxylase deficiency inherited and acquired disorders of biotin metabolism Int J Vitam Nutr Res 67 1997 377 384
29. A.K. Shetty, R.D. Craver, J.A. Harris Delayed diagnosis of fatal medium-chain acyl-CoA dehydrogenase deficiency in a child Pediatr Emerg Care 15 1999 399 401
30. R. Ziadeh, E.P. Hoffman, D.N. Finegold Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania neonatal screening shows high incidence and unexpected mutation frequencies Pediatr Res 37 1995 675 678
31. D.H. Chace, T.A. Kalas, E.W. Naylor Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns Clin Chem 49 2003 1797 1817
32. K. Carpenter, V. Wiley, K.G. Sim Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275,000 babies Arch Dis Child Fetal Neonatal Ed 85 2001 F105 F109
33. K.H. Carpenter, V. Wiley Application of tandem mass spectrometry to biochemical genetics and newborn screening Clin Chim Acta 322 2002 1 10
34. P. Rinaldo, D. Matern Disorders of fatty acid transport and mitochondrial oxidation challenges and dilemmas of metabolic evaluation Genet Med 2 2000 338 344
35. R.P. Insinga, R.H. Laessig, G.L. Hoffman Newborn screening with tandem mass spectrometry examining its cost-effectiveness in the Wisconsin Newborn Screening Panel J Pediatr 141 2002 524 531
36. P. Rinaldo, S. Tortorelli, D. Matern Recent developments and new applications of tandem mass spectrometry in newborn screening Curr Opin Pediatr 16 2004 427 433
37. D. Matern, M.J. Magera, N. Gunawardena Newborn screening for tyrosinemia type I first experience with a two-tiered approach Mol Genet Metab 84 2005 230
38. H. Ogier de Baulny Management and emergency treatments of neonates with a suspicion of inborn errors of metabolism Semin Neonatol 7 2002 17 26
39. S.E. Waisbren, S. Albers, S. Amato Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress J Am Med Assoc 290 2003 2564 2572
40. J.S. Wagener, M.K. Sontag, S.D. Sagel Update on newborn screening for cystic fibrosis Curr Opin Pulm Med 10 2004 500 504
41. N.S. Green, K.A. Pass Neonatal screening by DNA microarray spots and chips Nat Rev Genet 6 2005 147 151
42. B.K. Weis Standardizing global gene expression analysis between laboratories and across platforms Nat Methods 2 2005 351 356
43. P.J. Meikle, M.J. Fietz, J.J. Hopwood Diagnosis of lysosomal storage disorders current techniques and future directions Expert Rev Mol Diagn 4 2004 677 691
44. J.M. Green, J. Hewison, H.L. Bekker Psychosocial aspects of genetic screening of pregnant women and newborns a systematic review Health Technol Assess 8 2004 1 109 iii,ix-x
45. S. Oliver, C. Dezateux, J. Kavanagh Disclosing to parents newborn carrier status identified by routine blood spot screening Cochrane Database Syst Rev 18 2004 CD003859
46. M.R. Natowicz, E.H. Hiller Addressing consumer grievances in medicine policies and practices of newborn screening programs in the United States Genet Test 6 2002 31 38
47. F.E. Shafer, F. Lorey, G.C. Cunningham Newborn screening for sickle cell disease 4 years of experience from California's newborn screening program J Pediatr Hematol Oncol 18 1996 36 41 [see comments]
48. B. Wilcken Ethical issues in newborn screening and the impact of new technologies Eur J Pediatr 162 suppl 1 2003 S62 S66
49. K.D. Mandl, S. Feit, C. Larson Newborn screening program practices in the United States notification, research, and consent Pediatrics 109 2002 269 273
50. ACGME. Available at: http://www.acgme.org/acwebsite/irc/irc_compIntro. asp. Accessed May 27, 2005
51. Organic acidemias. an overview. Updated 12/2003. GeneReviews at GeneTests: Medical Genetics Information Resource (database online). Copyright, University of Washington, Seattle, 1997-2004. Available at: http://www. genetests.org. Accessed March 13, 2004
52. R.D. Steiner, S.D. Cederbaum Laboratory evaluation of urea cycle disorders J Pediatr 138 suppl 1 2001 S21 S29
53. T.H. Zytkovicz, E.F. Fitzgerald, D. Marsden Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots a two-year summary from the New England Newborn Screening Program Clin Chem 47 2001 1945 1955
54. Y. Li, C.R. Scott, N.A. Chamoles Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening Clin Chem 50 2004 1785 1796